These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8497274)

  • 1. Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation.
    Tikhonenko AT; Hartman AR; Linial ML
    Mol Cell Biol; 1993 Jun; 13(6):3623-31. PubMed ID: 8497274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gag as well as myc sequences contribute to the transforming phenotype of the avian retrovirus FH3.
    Tikhonenko AT; Linial ML
    J Virol; 1992 Feb; 66(2):946-55. PubMed ID: 1731115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages.
    Farina SF; Huff JL; Parsons JT
    J Virol; 1992 May; 66(5):2698-708. PubMed ID: 1313895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An avian retrovirus expressing chicken pp59c-myc possesses weak transforming activity distinct from v-myc that may be modulated by adjacent normal cell neighbors.
    Filardo EJ; Humphries EH
    J Virol; 1991 Dec; 65(12):6621-9. PubMed ID: 1942247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
    Min S; Mascarenhas NT; Taparowsky EJ
    Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation.
    Mäkelä TP; Koskinen PJ; Västrik I; Alitalo K
    Science; 1992 Apr; 256(5055):373-7. PubMed ID: 1566084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype.
    Tikhonenko AT; Black DJ; Linial ML
    Oncogene; 1995 Oct; 11(8):1499-508. PubMed ID: 7478574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of mutant and wild-type MC29 v-myc alleles and biochemical properties of their protein products.
    Bister K; Trachmann C; Jansen HW; Schroeer B; Patschinsky T
    Oncogene; 1987 May; 1(2):97-109. PubMed ID: 3438084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming ability of Gag-Myc fusion proteins correlates with Gag-Myc protein stability and transcriptional repression.
    Law W; Linial ML
    Oncogene; 2001 Mar; 20(9):1118-27. PubMed ID: 11314049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.
    Crouch DH; Fisher F; La Rocca SA; Goding CR; Gillespie DA
    Nucleic Acids Res; 2005; 33(16):5235-42. PubMed ID: 16166655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
    J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions.
    Prendergast GC; Hopewell R; Gorham BJ; Ziff EB
    Genes Dev; 1992 Dec; 6(12A):2429-39. PubMed ID: 1459463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
    Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two autonomous myc oncogenes in avian carcinoma virus OK10.
    Pfaff SL; Duesberg PH
    J Virol; 1988 Oct; 62(10):3703-9. PubMed ID: 3047429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
    Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription activation domains of v-Myc and VP16 interact with common factors required for cellular transformation and proliferation.
    Min S; Crider-Miller SJ; Taparowsky EJ
    Cell Growth Differ; 1994 Jun; 5(6):563-73. PubMed ID: 8086335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
    Billaud M; Isselbacher KJ; Bernards R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of gag-myc proteins from avian myelocytomatosis virus wild-type and mutants with chromatin.
    Bunte T; Greiser-Wilke I; Donner P; Moelling K
    EMBO J; 1982; 1(8):919-27. PubMed ID: 6329716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and transforming function of transduced mutant alleles of the chicken c-myc gene.
    Patschinsky T; Jansen HW; Blöcker H; Frank R; Bister K
    J Virol; 1986 Aug; 59(2):341-53. PubMed ID: 3016301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.